z-logo
open-access-imgOpen Access
To evaluate the safety and efficacy of saroglitazar among pre-diabetes and dyslipidemia
Author(s) -
Pravin G. Dhone,
Desabandhu Behera,
Vikas Gupta,
Mohd. Faheem Mubeen
Publication year - 2022
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns2.8835
Subject(s) - prediabetes , dyslipidemia , medicine , diabetes mellitus , prospective cohort study , impaired fasting glucose , endocrinology , type 2 diabetes , impaired glucose tolerance

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here